These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 21606568

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.
    Chu LW, Yik PY, Mok W, Chung CP.
    Int J Clin Pract; 2007 Mar; 61(3):403-10. PubMed ID: 17313606
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease.
    Rockwood K, Fay S, Gorman M.
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):191-201. PubMed ID: 19548273
    [Abstract] [Full Text] [Related]

  • 7. Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease.
    Brodaty H, Corey-Bloom J, Potocnik FC, Truyen L, Gold M, Damaraju CR.
    Dement Geriatr Cogn Disord; 2005 Feb; 20(2-3):120-32. PubMed ID: 15990426
    [Abstract] [Full Text] [Related]

  • 8. Galantamine for Alzheimer's disease.
    Olin J, Schneider L.
    Cochrane Database Syst Rev; 2002 Feb; (3):CD001747. PubMed ID: 12137632
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of galantamine in patients with mild Alzheimer's disease.
    Orgogozo JM, Small GW, Hammond G, Van Baelen B, Schwalen S.
    Curr Med Res Opin; 2004 Nov; 20(11):1815-20. PubMed ID: 15537482
    [Abstract] [Full Text] [Related]

  • 12. Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period.
    López-Pousa S, Turon-Estrada A, Garre-Olmo J, Pericot-Nierga I, Lozano-Gallego M, Vilalta-Franch M, Hernández-Ferràndiz M, Morante-Muñoz V, Isern-Vila A, Gelada-Batlle E, Majó-Llopart J.
    Dement Geriatr Cogn Disord; 2005 Nov; 19(4):189-95. PubMed ID: 15677866
    [Abstract] [Full Text] [Related]

  • 13. Two galantamine titration regimens in patients switched from donepezil.
    Engedal K, Davis B, Richarz U, Han J, Schäuble B, Andreasen N.
    Acta Neurol Scand; 2012 Jul; 126(1):37-44. PubMed ID: 21992111
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen.
    Thavichachart N, Phanthumchinda K, Chankrachang S, Praditsuwan R, Nidhinandana S, Senanarong V, Poungvarin N.
    Int J Clin Pract; 2006 May; 60(5):533-40. PubMed ID: 16700849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.